Executive Director and Head, Patient Centered Outcomes ScienceBioMarin Pharmaceutical Inc.Novato, California, United States
OC 30.3 - Health-related quality-of-life outcomes 4 years after treatment with valoctocogene roxaparvovec
Monday, June 24, 202410:00 – 10:15 ICT